迪奥司林:糖尿病和并发症的治疗潜力
Haoyang Gao1, Ze Wang1, Danlin Zhu1
1Shanghai Key Lab of Human Performance (Shanghai University of sport), Shanghai University of Sport, Shanghai 200438, China; The Key Lab of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport, Shanghai 200438, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|December 28, 2023
概括
天然化合物迪奥辛 (dioscin) 通过改善血糖控制和减少并发症,显示出治疗糖尿病的前景. 需要进一步的研究来确认其在人体试验中的安全性和有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 代谢障碍 代谢障碍 代谢障碍
- 自然产品 自然产品
背景情况:
- 糖尿病是一种全球性健康问题,其发病率和严重并发症正在增加.
- 目前治疗糖尿病的方法往往有副作用,需要寻找更安全的替代方案.
- 氨酸是一种植物性化合物,具有潜在的抗糖尿病特性.
研究的目的:
- 审查目前对迪奥辛对糖尿病及其并发症的治疗效果的理解.
- 为了探索底层 dioscin 的作用的潜在机制.
- 确定研究中的差距,并建议未来临床应用的方向.
主要方法:
- 对 dioscin 和糖尿病相关的现有科学文献进行系统审查.
- 对研究迪奥辛对葡萄糖和脂质代谢,小岛细胞保护,胰岛素抵抗,氧化应激和炎症的影响的分析.
- 评估关于迪奥司因预防和治疗潜力的初步数据.
主要成果:
- 迪奥辛显示出多方面的益处,包括调节葡萄糖和脂质代谢,保护岛屿β细胞和减轻胰岛素抵抗.
- 迪奥辛具有抗炎和抗氧化特性,对于治疗糖尿病并发症至关重要.
- 由于毒性降低,植物衍生迪奥辛提供了一种可能比合成抗糖尿病药物更安全的替代品.
结论:
- 迪奥辛是一种有希望的天然化合物,用于预防和治疗糖尿病及其相关并发症.
- 虽然初步数据令人鼓舞,但进一步的高质量人体研究和临床试验对于确定迪奥辛的安全性和有效性至关重要.
- 了解迪奥斯的分子机制需要进一步的研究,以优化其治疗应用.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
01:15Diabetes: Symptoms, Diagnosis, and Complications
549
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
549
01:23Dipeptidyl Peptidase 4 Inhibitors
188
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
188
01:22Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
206
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
206
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K